Cambridge Nutritional SciencesFRA:RVKA PB Ratio is 0.25 as of Jun. 27, 2026, which is 71% below its 10-year median of 0.85. The stock has 3 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Cambridge Nutritional Sciences ranks better than 95.18% on this metric.
Cambridge Nutritional Sciences PLC stock PB Ratio (=0.38) is close to 3-year low of 0.36.
The historical rank and industry rank for Cambridge Nutritional Sciences's PB Ratio or its related term are showing as below:
FRA:RVKA'
s PB Ratio Range Over the Past 10 Years
Min: 0.31 Med: 0.85 Max: 12.02
Current: 0.38
During the past 13 years, Cambridge Nutritional Sciences's highest PB Ratio was 12.02. The lowest was 0.31. And the median was 0.85.
FRA:RVKA's PB Ratio is ranked better than 95.18% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs FRA:RVKA: 0.38
During the past 12 months, Cambridge Nutritional Sciences's average Book Value Per Share Growth Rate was 15.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -9.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -18.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -15.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Cambridge Nutritional Sciences was 5.10% per year. The lowest was -31.60% per year. And the median was -13.30% per year.
Back to Basics: PB Ratio
Cambridge Nutritional Sciences (FRA:RVKA) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Cambridge Nutritional Sciences PB Ratio Related Terms
Cambridge Nutritional Sciences PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cambridge Nutritional Sciences PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's PB Ratio distribution charts can be found below:
* The bar in red indicates where Cambridge Nutritional Sciences's PB Ratio falls into.
Cambridge Nutritional Sciences PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Cambridge Nutritional Sciences (FRA:RVKA) has a PB Ratio of 0.25 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cambridge Nutritional Sciences and its competitors. This is 71% below median its historical median of 0.85. Over the past decade, Cambridge Nutritional Sciences' PB Ratio has ranged from 0.31 to 12.02. According to the industry distribution chart, Cambridge Nutritional Sciences ranks #38 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 4.8%.
Is Cambridge Nutritional Sciences' PB Ratio too high?
Cambridge Nutritional Sciences' current PB Ratio of 0.25 is 71% below median its 10-year median of 0.85. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 12.02. The Medical Devices & Instruments industry median PB Ratio is 2.02. Cambridge Nutritional Sciences' value of 0.25 is 87.6% below this industry median. Based on the distribution chart, Cambridge Nutritional Sciences ranks #38 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Cambridge Nutritional Sciences' PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Cambridge Nutritional Sciences ranks #38 out of 788 companies for PB Ratio. This places Cambridge Nutritional Sciences in the top 5% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.02. Cambridge Nutritional Sciences' value of 0.25 is 87.6% below this benchmark. Historically, Cambridge Nutritional Sciences' own PB Ratio has ranged from 0.31 to 12.02 over the past decade. While the company's 10-year median is 0.85 vs. the industry median of 2.02, Cambridge Nutritional Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cambridge Nutritional Sciences's current PB Ratio of 0.25 is 87.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Cambridge Nutritional Sciences and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cambridge Nutritional Sciences's current PB Ratio is 0.25, which is 71% below median its own 10-year median of 0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Based on GuruFocus' analysis, Cambridge Nutritional Sciences (FRA:RVKA) is currently considered Possible Value Trap. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 32.5% below its estimated fair value. The current PB Ratio is 0.25, which is 71% below median its 10-year median of 0.85 and 87.6% below the Medical Devices & Instruments industry median of 2.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Cambridge Nutritional Sciences (FRA:RVKA), the current PB Ratio is 0.25 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cambridge Nutritional Sciences Business Description
Cambridge Nutritional Sciences PLC is a medical diagnostics company specializing in the development, manufacture, and distribution of food sensitivity test kits. Its product portfolio includes tests designed to detect immune reactions to various foods, helping healthcare professionals and patients identify dietary and lifestyle changes to improve long-term health and wellbeing. The company operates in the United Kingdom and serves the customer base across various countries through laboratories and healthcare providers. It generates revenue by selling diagnostic kits and providing clinical analysis services centered on food sensitivity and gut health. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition segment generates majority revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RVKA has been successfully added to your 